Lipid Therapeutics GmbH:
About Lipid Therapeutics
Lipid Therapeutics is a biopharmaceutical company focused on the development and commercialization of phospholipids for the treatment of ulcerative colitis. Based on groundbreaking scientific work by Prof. Wolfgang Stremmel at Krehl University Hospital in Heidelberg, the company was founded in 2008. Lipid Therapeutics is based in Heidelberg and is funded by the EMBL Technology Fund. In August 2009, Lipid Therapeutics and market leader Dr. Falk Pharma, Freiburg, signed an agreement to jointly develop and license LT-02.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Pharma
News about Lipid Therapeutics
Here you will find Lipid Therapeutics GmbH:
Last viewed contents
FRIEDRICHS FILTERSYSTEME GMBH - Wassenberg, Germany
Amgen Names Yuji Orihara President, Amgen KK
Amgen and Genentech settle patent dispute
Amgen Names Robert Bradway Executive Vice President and Chief Financial Officer
Prednisone
Pharma Stulln GmbH - Stulln, Germany
FP-Anlagentechnik und Service - Pfofeld, Germany
Oswaldo Cruz Foundation and Genzyme Corporation Form Collaboration To Advance New Drugs for Neglected Diseases
